Abstract:Objectives Diffuse large B-cell lymphoma (DLBCL) is a disease with highly heterogeneous molecular characteristics and clinical course. Refractory/relapsed DLBCL shows poor prognosis, and new therapeutic approaches are urgently needed to improve its clinical outcomes. It is important to investigate the mechanism of development of DLBCL, in order to discover new molecular therapeutic targets. In this study, Cytometry by Time-Of-Flight mass spectrometry (CyTOF) was used to profile the immune cells in peripheral blood of DLBCL patients, to investigate the changes of immune cell subpopulation, and to find possible new targets for immune therapy of DLBCL. Methods Two CyTOF antibody panels targeting innate and adaptive immune cells, respectively, were designed to detect the characteristics of immune cell subpopulation. The antibodies include cell surface, intracellular and nuclear markers, targeting immune-related functions such as cell phenotyping, activation, proliferation, immune checkpoints, and chemokine receptors. Peripheral blood was collected from 50 DLBCL patients and 14 healthy controls. After staining and data collection, dimensional reduction such as viSNE and clustering such as SPADE and PARC were performed in Cytobank, OMIQ and R to comprehensively compare the differences in cell subset composition and function between patients and healthy controls. Results CD8+ T cells were more differentiated into effector phenotype with senescence and exhausted characteristics in DLBCL patients CD8+ T cells decreased significantly in DLBCL patients. Percentages of effector memory (EM) and CD45RA+ effector memory cells (EMRA) in CD8+ T cells were elevated in DLBCL patients. The higher expression intensities of CD45RO, KLRG1, PD-1, CTLA-4, and TIGIT in CD8+T cells imply the senescence and exhausted characteristics of CD8+ T cells in patients. After clustering analysis by SPADE, CD8+ T cells could be divided into 4 clusters, among which the proportion of CD45RO+KLRG1+ cluster was significantly higher in patients. This subset highly expressed PD-1, CTLA-4, TIGIT, GITR, CD25, and FoxP3, suggesting that they are exhausted effector CD8+ T cells with immunosuppressive phenotype. Proportions of the other 3 clusters, which were CD27+CCR7+ naïve CD8+ T cells, Granzyme B+HLA-DR+Ki-67+ central memory CD8+ T cells, and Granzyme B+HLA-DR+ central memory CD8+ T cells respectively, did not change significantly. CD56brightNK cell subset decreased significantly in DLBCL patients NK cells decreased significantly in DLBCL patients. By PARC clustering analysis, NK cells were divided into 3 clusters. The patient had a significantly reduced CD56bright subset. While, CD56brightKi-67+ cluster as well as CD56dimCD16+ cluster did not significantly change. Two subsets of monocytes with immunosuppressive phenotype emerged in DLBCL patients Compared with healthy controls, monocytes showed a significant elevation in DLBCL patients. However, the proportion of CD14+HLA-DR+ monocytes decreased in patients. 2 subsets of CD33+CD11b+ and BDCA3+CXCR3+ monocytes appeared, which showed higher expression of immunosuppression-related markers CD163, PD-1, and LAG3, and relatively lower expression of HLA-DR. (Figure 1) CD33+CD11b+ cells were consistent with the MDSC phenotype; whereas the proportion of BDCA3+CXCR3+ subset in total leukocytes correlated with patients' treatment response for chemotherapy. The level of BDCA3+CXCR3+ monocytes was significantly higher in patients who obtained CR after 6 cycles of chemotherapy than in patients who did not. (Figure 2) Conclusions By a multidimensional CyTOF staining approach, we depicted the immune cell profile of peripheral blood in DLBCL patients, analyzed the changes of the proportion of immune cell subset, and explored the changes in differentiation and function of different immune cell subsets in depth. For the first time, we found an increase in BDCA3+CXCR3+ monocyte subpopulation in DLBCL patients, and its proportion may be closely related to the prognosis of DLBCL patients. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal

Molecular investigations on T cell subsets in patients affected by hypomorphic DCLRE1C mutation

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Variable clinical presentation of hypomorphic DCLRE1C deficiency from childhood to adulthood

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Investigation of Transcription Factor and Cytokine Gene Expression Levels in Helper T Cell Subsets Among Turkish Patients Diagnosed with ICF2 (Novel ZBTB24 gene Variant) and ICF3 (CDCA7 Variant) Syndrome

DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.

Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B

Altered Ligand-Interaction Contributes to Functional Insufficiency Due to CTLA-4 Gene Mutation

Characterization of Conserved CDR3 Sequence of TCRα- Andβ-Chain Genes in Peripheral Blood T-cells from Patients with Diffuse Large B-cell Lymphoma

The Research of TCR Vβ Clonality Distribution in Patients with Diffuse Large B-Cell Lymphoma and Its Clinical Significance

Alteration of the Gene Expression Profile of T-cell Receptor Αβ-Modified T-cells with Diffuse Large B-cell Lymphoma Specificity.

The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma

High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma

Gene Expression Profiling and Immune Cell-Type Deconvolution Highlight Robust Disease Progression and Survival Markers in Multiple Cohorts of CTCL Patients.

Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model.

Association of NK cell subsets and cytotoxicity with FCGR3A gene polymorphism in functional NK cell deficiency

Profiling Immune Cells in DLBCL Patients with Mass Cytometry by Time-of-Flight (Cytof)

Different Aberrant Expression Pattern of Immune Checkpoint Receptors in Patients with PTCL and NK/T-CL.

Characteristics of TCRζ, ZAP-70, and FcɛRIγ Gene Expression in Patients with T- and NK/T-Cell Lymphoma

Impaired B-cell function in ERCC2 deficiency

Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients